[How to take into account the cost effectiveness parameters in the management of bronchial carcinoma?].
Vergnenègre
A
A
Service de l'Information Médicale et de l'Evaluation, Hôpital du Cluzeau - 87042 Limoges Cedex. alain.vergnenegre@unilim.fr
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics / Q000627:therapeutic use; D024221:Antineoplastic Protocols / Q000592:standards; D003362:Cost-Benefit Analysis; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000191:economics* / Q000628:therapy*; D019057:Quality-Adjusted Life Years; D016032:Randomized Controlled Trials as Topic